The Clinical Operations and Data Management team at Trishula Therapeutics is responsible for the planning, execution, and management of clinical trials for their flagship anti-CD39 antibody, TTX-030. This team ensures the efficient operation of clinical studies, oversees patient data integrity, compliance with regulatory standards, and facilitates data analysis to advance the development of cancer immunotherapy solutions.
View all